Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low

Frederic Deschaseaux1, Florelle Gindraux, Rafika Saadi

  • 1MEN EA 2284, Institut d'Etude et de Transfert de Gènes, Besançon, France. fdechaseaux@chu-besancon.fr

Insights

Researchers developed a direct method to isolate human bone marrow mesenchymal stem cells (MSC) using CD49a and CD45 markers. This technique preserves their differentiation potential for various cell types.

Area of Science:

  • Stem Cell Biology
  • Hematology
  • Immunophenotyping

Background:

  • Human bone marrow mesenchymal stem cells (MSC) are crucial for generating various cell types.
  • Current isolation methods are indirect and do not fully characterize in vivo MSC phenotypes.

Purpose of the Study:

  • To develop a direct selection method for human bone marrow MSC.
  • To determine the phenotype of MSC isolated via this direct method.

Main Methods:

  • Mesenchymal cells were selected using anti-CD49a and anti-CD45 antibodies via flow cytometry and magnetic beads.
  • Fibroblast colony-forming unit (CFU-F) potential and differentiation capacity were assessed.
  • Phenotypic analysis of uncultured and cultured cells was performed using flow cytometry.

Main Results:

  • Fibroblast colony-forming units (CFU-F) were exclusively found in the CD49a-positive cell population.
  • Direct selection identified a CD49a+/CD45med,low population with MSC potential.
  • In vitro culture downregulated CD45 expression while maintaining differentiation capacity.

Conclusions:

  • A direct, efficient method using CD49a and CD45 markers for isolating human bone marrow MSC was established.
  • This method preserves the multipotent differentiation capacity of MSC.
  • The CD45 marker, downregulated upon culture, is key for direct MSC selection.

Related Concept Videos